...
首页> 外文期刊>Science in China. Series C, Life science >Selection of trkB - binding peptides from a phage-displayed random peptide library
【24h】

Selection of trkB - binding peptides from a phage-displayed random peptide library

机译:从噬菌体展示的随机肽库中选择trkB结合肽

获取原文
获取原文并翻译 | 示例

摘要

Brain-derived neurotrophic factor (BDNF) shows potential in the treatment of neurode-generative diseases, but the therapeutic application of BDNF has been greatly limited because it is too large in molecular size to permeate blood-brain barrier. To develop low-molecular-weight BDNF-like peptides, we selected a phage-displayed random peptide library using trkB expressed on NIH 3T3 cells as target in the study. With the strategy of peptide library incubation with NIH 3T3 cells and competitive elution with 1 μg/mL of BDNF in the last round of selection, the specific phages able to bind to the natural conformation of trkB and antagonize BDNF binding to trkB were enriched effectively. Five trkB-binding peptides were obtained, in which a core sequence of CRA/TXφXXφXXC (X represents the random amino acids, φ represents T, L or I) was identified. The BDNF-like activity of these five peptides displayed on phages was not observed, though all of them antagonized the activity of BDNF in a dose-dependent manner. Similar results were obtained with the synthetic peptide of C1 clone, indicating that the 5 phage-derived peptides were trkB antagonists. These low-molecular-weight antagonists of trkB may be of potential application in the treatment of neuroblastoma and chronic pain. Meanwhile, the obtained core sequence also could be used as the base to construct the secondary phage-displayed peptide library for further development of small peptides mimicking BDNF activity.
机译:脑源性神经营养因子(BDNF)在治疗神经退行性疾病方面显示出潜力,但由于BDNF的分子大小太大而无法渗透血脑屏障,因此其治疗应用受到极大限制。为了开发低分子量的BDNF样肽,我们选择了在NIH 3T3细胞上表达的trkB作为研究对象的噬菌体展示随机肽文库。通过在NIH 3T3细胞中孵育肽库并在最后一轮选择中以1μg/ mL BDNF进行竞争性洗脱的策略,能够与trkB的天然构象结合并拮抗BDNF与trkB结合的特异性噬菌体得到了有效富集。获得了五个trkB结合肽,其中鉴定了CRA /TXφXXφXXC的核心序列(X代表随机氨基酸,φ代表T,L或I)。尽管它们全部以剂量依赖性方式拮抗BDNF的活性,但未观察到在噬菌体上展示的这五个肽的BDNF样活性。用C1克隆的合成肽获得了相似的结果,表明5种噬菌体衍生的肽是trkB拮抗剂。这些trkB的低分子量拮抗剂可能在神经母细胞瘤和慢性疼痛的治疗中具有潜在的应用前景。同时,获得的核心序列也可以用作构建二级噬菌体展示肽库的基础,以进一步开发模仿BDNF活性的小肽。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号